Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
Manual for Picking Coastline Travel - 2These 2 moon rovers used cameras and lasers to hunt for simulated water ice — and one looks like WALL-E
- 3Manual for Famous Beverages 2024
- 4How Seniors Can Use Refunds and Motivators to Purchase a Hyundai Ioniq EV
- 5Every year, she thanks the trooper for the arrest that led to her sobriety
- More loons are filling Maine's lakes with their ghostlike calls
- Video Conferencing Instruments for Virtual Gatherings
- Is Iran using cryptocurrencies to circumvent sanctions?
- Poll: By a 2-to-1 margin, Americans say Trump has done more to raise prices than lower them
- Bruno Mars tour 2026: How to get tickets for 'The Romantic Tour,' presale times, prices and more
- A new mom skipped a routine appointment. An infected cut led to a devastating diagnosis
- A Concise History Of The Entertainment world
- New movies to watch this weekend: See 'The Running Man' in theaters, rent 'One Battle After Another,' stream 'Nobody 2' on Peacock
- Mobility exercises are an important part of fitness as we age. Here are some tips
